Efficacy of glycopyrronium bromide and scopolamine hydrobromide in patients with death rattle: A randomized controlled study;Die wirkung von glycopyrroniumbromid im vergleich mit scopolamin- hydrobromicum beim terminalen rasseln: Eine randomisierte, doppelblinde pilotstudie

Wiener Klinische Wochenschrift

Volumn 120, Issue 21-22, 2008, Pages 679-683

  Likar, Rudolf ^a   Rupacher, Ernst ^a   Kager, Hans ^a   Molnar, Mario ^a   Pipam, Wofgang ^a   Sittl, Reinhard ^b  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cancer patients; Death rattle; Glycopyrronium bromide; Scopolamine hydrobromide

Indexed keywords

ANALGESIC AGENT; GLYCOPYRRONIUM BROMIDE; SCOPOLAMINE BROMIDE; SEDATIVE AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT;

ABNORMAL RESPIRATORY SOUND; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH RATTLE; DRUG EFFICACY; HUMAN; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; TERMINALLY ILL PATIENT; TREATMENT OUTCOME; AGED; BODILY SECRETIONS; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; MALE; PILOT STUDY; PLACEBO EFFECT; PROCEDURES; TERMINAL CARE;

AGED; BODILY SECRETIONS; DOUBLE-BLIND METHOD; FEMALE; GLYCOPYRROLATE; HUMANS; MALE; MUSCARINIC ANTAGONISTS; PARASYMPATHOLYTICS; PILOT PROJECTS; PLACEBO EFFECT; RESPIRATORY SOUNDS; SCOPOLAMINE; TERMINAL CARE; TREATMENT OUTCOME; SCOPOLAMINE HYDROBROMIDE;

EID: 58149316605     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-008-1094-2     Document Type: Article

References (17)

1. S Dalal E Del Fabbro E Bruera 2006 Symptom control in palliative care - Part I: oncology as a paradigmatic example J Palliativ Med 9 2 391 408
2. JE Ellershaw JM Sutcliffe CM Saunders 1995 Dehydration and the dying patient J Pain Symptom Manage 10 192 197
3. MI Bennett 1996 Death rattle: an audit of hyoscine (scopolamine) use and review of management J Pain Symptom Manage 12 229 233
4. I Lichter E Hunt 1990 The last 48 hours of life J Palliat Care 6 7 15
5. C Bausewein R Twycross 1995 Comparative cost of hyoscine injections Palliat Med 9 256
6. BL Wee PG Coleman R Hillier SH Holgate 2006 The sound of death rattle I: are relatives distressed by hearing this sound? Palliative Medicine 20 171 175
7. BL Wee PG Coleman R Hillier SH Holgate 2006 The sound of death rattle II: ho do relatives interpret the sound? Palliative Medicine 20 177 181
8. D Power M Daerney 1992 Management of the final 24 hours Ir Med J 85 93 95
9. M Bennet V Lucas M Brennan A Hughes V O'Donnell B Wee 2002 Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care Palliative Medicine 16 369 374
10. A Hughes A Wilcock R Corcoran V Lucas A King 2000 Audit of three antimuscarinic drugs for managing retained secretions Palliative Medicine 14 221 222
11. R Likar M Molnar E Rupacher W Pipam J Deutsch M Mörtl J Baumgartner N Grießinger R Sittl 2002 Klinische Untersuchung über die Wirkung von Scopolamin-Hydrobromicum beim terminalen Rasseln (randomisierte, doppelblinde, placebokontrollierte Studie) Z Palliativmed 3 15 19
12. T Morita J Tsunada S Inoue S Chihara 2000 Risk factors death rattle in terminally ill cancer patients: a prospective exploratory study Palliative Medicine 14 19 23
13. T Morita J Tsunada S Inoue S Chihara 1999 Contributing factors of physical symptoms in terminally ill cancer patients J Pain Symptom Manage 18 338 346
14. IN Back K Jenkins A Blower J Beckhelling 2001 A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle Palliative Medicine 15 329 336
15. H Lawrey 2005 Hyoscine vs glycopyrronium for drying respiratory secretions in dying patients Br J Community Nurs 10 9 421 424 426
16. Wee B, Hillier R (2008) Interventions for noisy breathing in patients near to death. Cochrane Database Syst Rev Jan 23; (1): CD005177
17. T Ali Melkhila J Kanto E Ilsalo 1993 Pharmacokinetics and related pharmacodynamics and anticholinergic drugs Acta Anaesthesiol Scand 37 633 642